当前位置: X-MOL 学术Indian J. Microbiol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Deploying Biomolecules as Anti-COVID-19 Agents.
Indian Journal of Microbiology ( IF 2.1 ) Pub Date : 2020-06-09 , DOI: 10.1007/s12088-020-00893-4
Sanjay K S Patel 1 , Jung-Kul Lee 1 , Vipin C Kalia 1
Affiliation  

Severe acute respiratory syndrome coronavirus (SARS-CoV-2) known as COVID-19 has emerged as a major threat to human existence. COVID-19 seems to have undergone adaptive evolution through an intermediate host, most likely bats. The flu leads to severe pneumonia that causes respiratory and multi-organ failure. The absence of any known treatment procedures, drugs, or vaccines has created panic around the World. The need is to develop rapid testing kits, drugs and vaccines. However, these proposals are time-consuming processes. At present social distancing along with previously known traditional medicines can act as quick and short-term alternatives for treating this viral flu.

中文翻译:

使用生物分子作为抗 COVID-19 药物。

严重急性呼吸综合征冠状病毒(SARS-CoV-2)(称为 COVID-19)已成为人类生存的主要威胁。COVID-19 似乎通过中间宿主(最有可能是蝙蝠)经历了适应性进化。流感会导致严重肺炎,导致呼吸系统和多器官衰竭。由于缺乏任何已知的治疗程序、药物或疫苗,已经在世界各地引起了恐慌。需要开发快速检测试剂盒、药物和疫苗。然而,这些建议是一个耗时的过程。目前,社交距离和以前已知的传统药物可以作为治疗这种病毒性流感的快速和短期替代方案。
更新日期:2020-06-09
down
wechat
bug